French pharma giant Sanofi has completed the acquisition of Dynavax Technologies, gaining its hepatitis-B vaccine and vaccine pipeline.
π Why big: Global vaccine giants are consolidating portfolios ahead of future infectious disease waves.
π Source: https://www.sanofi.com/en/media-room/press-releases/2026/2026-02-10-14-00-56-3235419
CenterWell (Humana division) acquires MaxHealth clinics
US healthcare services major CenterWell has completed acquisition of MaxHealth, expanding its primary-care network footprint.
π Why big: Insurers are aggressively buying clinics to control patient journey & costs (payer β provider model).
Ampersand Capital acquires Purna Pharmaceuticals
Private equity firm Ampersand Capital Partners has acquired Purna Pharmaceuticals, a CDMO drug manufacturer.
π Why big: Investors betting on contract manufacturing β the backbone of global pharma outsourcing.
Tilray expands pharma distribution partnership in UK
Tilrayβs subsidiary CC Pharma signed a strategic agreement with Smartway Pharmaceuticals to expand medicine supply distribution.
π Why big: Distribution networks are becoming strategic assets amid medicine shortages.
Zuellig Pharma acquires consumer healthcare brands from Bayer
Asian healthcare solutions company Zuellig Pharma acquired Zam-Buk & Vapex brands from Bayer.
π Why big: Consumer healthcare (OTC) is the fastest-growing pharma revenue stream in Asia.

Leave a Comment